Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stella Cascioferro

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Chemmedchem|August 25, 2025
Novel Pyrazolo [1,5-a]-1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma ModelsDaniela Carbone, Francesca Terrana, Ludovica Sciuto, et al.
European Journal of Medicinal Chemistry|February 18, 2019
2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent staphylococcal biofilm inhibitorsStella Cascioferro, Barbara Parrino, Giovanna Li Petri, et al.
Archiv Der Pharmazie|May 6, 2009
N-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studiesDemetrio Raffa, Benedetta Maggio, Stella Cascioferro, et al.
Molecules (Basel, Switzerland)|February 25, 2016
Discovery of a New Class of Sortase A Transpeptidase Inhibitors to Tackle Gram-Positive Pathogens: 2-(2-Phenylhydrazinylidene)alkanoic Acids and Related DerivativesBenedetta Maggio, Demetrio Raffa, Maria Valeria Raimondi, et al.
European Journal of Medicinal Chemistry|January 29, 2023
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluationCamilla Pecoraro, Michele De Franco, Daniela Carbone, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 18, 2019
Pharmacogenetics of treatments for pancreatic cancerBtissame El Hassouni, Giovanna Li Petri, Daniel S K Liu, et al.
European Journal of Medicinal Chemistry|December 7, 2010
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activityBenedetta Maggio, Maria Valeria Raimondi, Demetrio Raffa, et al.
International Journal of Molecular Sciences|February 25, 2023
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal AdenocarcinomaDaniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
Bioorganic & Medicinal Chemistry|September 8, 2015
Synthesis, antiproliferative activity and possible mechanism of action of novel 2-acetamidobenzamides bearing the 2-phenoxy functionalityDemetrio Raffa, Benedetta Maggio, Fabiana Plescia, et al.
Journal of Drug Targeting|July 27, 2024
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profileCamilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Chemmedchem|August 25, 2025
Novel Pyrazolo [1,5-a]-1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma ModelsDaniela Carbone, Francesca Terrana, Ludovica Sciuto, et al.
European Journal of Medicinal Chemistry|February 18, 2019
2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent staphylococcal biofilm inhibitorsStella Cascioferro, Barbara Parrino, Giovanna Li Petri, et al.
Archiv Der Pharmazie|May 6, 2009
N-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studiesDemetrio Raffa, Benedetta Maggio, Stella Cascioferro, et al.
Molecules (Basel, Switzerland)|February 25, 2016
Discovery of a New Class of Sortase A Transpeptidase Inhibitors to Tackle Gram-Positive Pathogens: 2-(2-Phenylhydrazinylidene)alkanoic Acids and Related DerivativesBenedetta Maggio, Demetrio Raffa, Maria Valeria Raimondi, et al.
European Journal of Medicinal Chemistry|January 29, 2023
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluationCamilla Pecoraro, Michele De Franco, Daniela Carbone, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 18, 2019
Pharmacogenetics of treatments for pancreatic cancerBtissame El Hassouni, Giovanna Li Petri, Daniel S K Liu, et al.
European Journal of Medicinal Chemistry|December 7, 2010
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activityBenedetta Maggio, Maria Valeria Raimondi, Demetrio Raffa, et al.
International Journal of Molecular Sciences|February 25, 2023
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal AdenocarcinomaDaniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
Bioorganic & Medicinal Chemistry|September 8, 2015
Synthesis, antiproliferative activity and possible mechanism of action of novel 2-acetamidobenzamides bearing the 2-phenoxy functionalityDemetrio Raffa, Benedetta Maggio, Fabiana Plescia, et al.
Journal of Drug Targeting|July 27, 2024
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profileCamilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.
Pageof 8